Model Integration and Configuration for Pharmacovigilance in

Data Characteristics in this Category

Pharmacovigilance data in health management originates primarily from patient Electronic Health Records (EHRs), wearable device records, voluntary patient reporting systems (e.g., adverse event reporting platforms), and professional medical institution monitoring reports. This data updates frequently. Some real-time data, such as physiological indicators from wearable devices, can update every second. Patient self-reports and EHR data might update daily or weekly. Document structures vary, including structured diagnostic records, drug prescriptions, and lab results, alongside large volumes of unstructured text like physician notes, patient chief complaints, and phone follow-up records. Fields include patient ID, age, gender, diagnostic disease codes (e.g., ICD-10), drug names (generic and brand), dosage, administration route, start and end dates of medication, adverse reaction descriptions (free text), adverse reaction occurrence time, severity, and outcome. Units involved include milligrams (mg), milliliters (ml), times/day, and hours (h).

Constraints Imposed by These Characteristics on "Model Integration and Configuration"

The high update frequency and multi-source nature of health management data demand that model integration includes efficient data synchronization mechanisms to ensure timely analysis. The coexistence of structured and unstructured data means models must handle both precise matching of structured fields and semantic understanding of unstructured text. Specifically, the large volume of free-text adverse reaction descriptions places high demands on the model's text processing capabilities, entity recognition, and event extraction. Diverse fields and units require models to perform standardization and normalization during the preprocessing phase to reduce ambiguity. Furthermore, patient privacy protection is a core constraint; data anonymization and access control must be strictly followed in model configuration. Large and dynamic datasets directly impact model inference performance and resource consumption, requiring a balance between model complexity and response time.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`modelName`	`qwen-plus`	Balances Chinese comprehension, long text processing, and inference speed, suitable for semantic analysis of complex adverse reaction descriptions.
`maxContext`	`16384 tokens`	Accommodates potentially long clinical records and multiple medication histories in EHRs, ensuring complete context.
`temperature`	`0.3`	Reduces the randomness of model-generated content, ensuring accuracy and consistency in pharmacovigilance analysis results.
`Chunk size`	`800 characters`	Balances text segmentation granularity with semantic integrity, suitable for splitting and indexing unstructured text.
`Recall count`	`10 entries`	Controls the context length passed to the large model while ensuring recall, reducing computational cost.
`Similarity threshold`	`0.75`	Filters out knowledge snippets highly relevant to the query, reducing interference from irrelevant information and improving inference efficiency.

Three Common Mistakes

Symptom: The model's thought process is missing or incomplete in the output. Reason: The outputThought parameter was not enabled or was overwritten in the model configuration, meaning the model was not explicitly instructed to output inference steps.
Symptom: When processing long text, the large model's actual output is truncated before reaching the maximum token limit, with a "reply limit exceeded" prompt. Reason: This usually occurs because the system or framework has an additional hard output token limit set lower than the model's advertised maximum output tokens. This means the model can process long inputs, but its output is cut short.
Symptom: The model misunderstands dosage or time information in adverse reaction descriptions, leading to misjudgments. Reason: Dosage and time expressions in free text are diverse and lack standardization. The model's generalization ability for fine-grained entity recognition in these cases is insufficient during pre-training or fine-tuning, requiring stronger named entity recognition capabilities or post-processing rules.

How to Confirm Proper Configuration

Submit test data containing typical adverse drug reaction cases. Observe whether the model accurately identifies key entities like drugs, adverse reactions, dosages, and times. Evaluate the extraction accuracy of critical information.
Upload test documents containing long clinical records and multiple medication histories. Check if the model can fully process the context and if the summarized or analyzed results cover all important information. Also, observe for any truncation prompts.
Adjust the temperature parameter and input the same query. Observe the consistency of the model's output results. Ensure that at a low temperature, stable and highly repeatable analysis conclusions are obtained, meeting the rigor required for pharmacovigilance.
Simulate data access and queries under high concurrency. Monitor the model's response time and resource utilization. Confirm that system performance meets the real-time requirements of health management scenarios. Adjust parameters like maxContext and Recall count based on actual conditions.

The values provided are common starting points. They should be measured against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.